0 CHECKOUT

PRODUCT FILTERS

REGION

273
218
202
131
26

COUNTRY

272
12
11
6
4

CATEGORIES

  • 591
  • 8
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

343
616
630
706

PUBLISHED

11
28
77
706

PRODUCT TYPE

568
93
22
17
4
1
1

Search for: "21st Century Holding Company"

21st Century Holdings Acquisition Manual

The Acquisition Manual on 21st Century Holdings is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all aspects of 21st Century...

Published:  August 2016
Price: 

21st Century Oncology Holdings, Inc.

This private company report on 21st Century Oncology Holdings, Inc. provides a detailed 21st Century Oncology Holdings, Inc. company profile, consisting of 21st Century Oncology Holdings, Inc. financials,...

Published:  August 2016
Price: 

Research Update: 21st Century Oncology Holdings Inc. Corporate Credit Rating Lowered To 'CCC' From 'B-'; On CreditWatch Negative May 16

Abstract On May 12, 2016, cancer care provider 21st Century Oncology Holdings Inc. received a notice of default from its lenders relating to the company's delayed 10-K filing for fiscal year-ended...

Published:  May 2016
Price: 

21st Century Oncology Holdings Inc. Corporate Credit Rating Raised To 'B-' On Debt Paydown; Outlook Stable Sep 14

Abstract 21st Century Oncology announced that it has issued $325 million in preferred stock and will be using a portion of the proceeds to pay down debt. We believe the transaction improves the company's...

Published:  September 2014
Price: 

Research Update: 21st Century Oncology Holdings Inc. 'B-' Corporate Credit Rating Affirmed; New Debt Rated Apr 15

Abstract Cancer care provider 21st Century Oncology Holdings Inc. is refinancing its capital structure. The transaction does not meaningfully affect already high leverage (which includes the preferred...

Published:  April 2015
Price: 

21st Century Oncology Holdings Inc. 'B-' Corporate Credit Rating Affirmed; New Debt Rated Apr 15

Abstract Cancer care provider 21st Century Oncology Holdings Inc. is refinancing its capital structure. The transaction does not meaningfully affect already high leverage (which includes the preferred...

Published:  April 2015
Price: 

Research Update: 21st Century Oncology Holdings Inc. Ratings On Watch Negative On Restated Financials And Delayed 10-K Mar 16

Abstract Cancer care provider 21st Century Oncology Holdings Inc. recently announced that it was restating its financial statements for the three years 2012-2014 and the first three quarters of 2015,...

Published:  March 2016
Price: 

Research Update: 21st Century Oncology Holdings Inc. Downgraded To 'CCC+' On Recapitalization Agreement; Outlook Negative Jul 14

Abstract 21st Century announced that it entered into a recapitalization agreement, stipulating that if its sponsors do not provide the company with an additional $150 million of liquidity, then the...

Published:  July 2014
Price: 

21st Century Oncology Holdings Inc. Downgraded To 'CCC+' On Recapitalization Agreement; Outlook Negative Jul 14

Abstract 21st Century announced that it entered into a recapitalization agreement, stipulating that if its sponsors do not provide the company with an additional $150 million of liquidity, then the...

Published:  July 2014
Price: 

Research Update: 21st Century Oncology Holdings Inc. Corporate Credit Rating Raised To 'B-' On Debt Paydown; Outlook Stable Sep 14

Abstract 21st Century Oncology announced that it has issued $325 million in preferred stock and will be using a portion of the proceeds to pay down debt. We believe the transaction improves the company's...

Published:  September 2014
Price: 

21st Century Oncology Holdings Inc. Ratings Unchanged On Add-On To First-Lien Debt And Reduction In Note Issuance Apr 15

Abstract NEW YORK (Standard & Poor's) April 28, 2015--Standard & Poor's Ratings Services said today that its ratings on 21st Century Oncology Holdings Inc.'s proposed first-lien credit facilities remain...

Published:  April 2015
Price: 

21st Century Oncology Holdings Inc. Outlook Revised To Negative After CMS Proposes Rate Cut; 'B-' Rating Affirmed Jul 14

Abstract The Center for Medicare and Medicaid Services (CMS), which sets payment rates for Medicare, announced a proposed rate cut of 4% for radiation oncology services. A cut of this magnitude could...

Published:  July 2014
Price: 

Research Update: 21st Century Oncology Holdings Inc. Outlook Revised To Negative After CMS Proposes Rate Cut; 'B-' Rating Affirmed Jul 14

Abstract The Center for Medicare and Medicaid Services (CMS), which sets payment rates for Medicare, announced a proposed rate cut of 4% for radiation oncology services. A cut of this magnitude could...

Published:  July 2014
Price: 

21st Century Holding Company : Company Profile and SWOT Analysis

Synopsis World Market Intelligence's '21st Century Holding Company : Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains...

Published:  March 2012
Price:  From

Q4 2014 Earnings Call - 21st Century Oncology Holdings, Inc., - Earnings Transcript

Q4 2014 Earnings Call - 21st Century Oncology Holdings, Inc., - Earnings Transcript Thursday, March 19, 2015 04:30

Published:  March 2015
Price: 

21st Century Oncology, Inc. - Strategic SWOT Analysis Review

21st Century Oncology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a...

Published:  June 2015
Price:  From

1st Century Bancshares, Inc. (FCTY) - Company Capsule

The "1st Century Bancshares, Inc. (FCTY) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products...

Published:  June 2015
Price:  From

Farmers Insurance Exchange Jul 16

Abstract Very strong competitive position Eighth-largest property/casualty (P/C) insurer in the U.S., with a leading presence in the personal lines marketplace Intermediate industry and country risk...

Published:  July 2016
Price: 

Farmers Insurance Exchange Jul 15

Abstract Very strong competitive position Eighth-largest property-casualty (P/C) writer in the U.S. with a leading presence in the personal lines marketplace Intermediate industry and country risk...

Published:  July 2015
Price: 

21st Century Insurance Co. of the Southwest Rated 'A+'; Related Ratings Affirmed Jan 06

Abstract NEW YORK (Standard & Poor's) Jan. 31, 2006--Standard & Poor's Ratings Services said today that it assigned its 'A+' counterparty credit and financial strength ratings to 21st Century Insurance...

Published:  January 2006
Price: 
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group